BRKR|Bruker Corp|Price:41.930|Chg%:0.89

More Details of Bruker Corp Company

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

Bruker Corp Info



Ticker SymbolBRKR

Company nameBruker Corp

IPO dateAug 04, 2000

CEOPrause (Burkhard A)

Number of employees11396

Security typeOrdinary Share

Fiscal year-endAug 04

Address40 Manning Rd

CityBILLERICA

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code01821-3915

Phone19786633660

Websitehttps://www.bruker.com/

Ticker SymbolBRKR

IPO dateAug 04, 2000

CEOPrause (Burkhard A)

Company Executives of Bruker Corp



Name

Name/Position

Position

Shareholding

Change

Dr. Frank H. Laukien, Ph.D.

Chairman of the Board, President, Chief Executive Officer

40.41M

+31932.00%

Dr. Mark Robert Munch, Ph.D.

Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division

95.36K

--

Mr. Richard A. Packer

Independent Director

85.88K

+4972.00%

Mr. Gerald N. Herman

Chief Financial Officer, Executive Vice President

70.13K

+20621.00%

Dr. Falko Busse, Ph.D.

President - Bruker BioSpin Group

35.59K

+9282.00%

Mr. John A. Ornell, CPA

Independent Director

31.91K

+3767.00%

Dr. Hermann Fritz Requardt, Ph.D.

Independent Director

23.15K

-921.00%

Ms. Adelene Q. Perkins

Independent Director

21.33K

-921.00%

Dr. Cynthia M. Friend, Ph.D.

Independent Director

14.72K

+765.00%

Ms. Bonnie H. Anderson

Independent Director

10.03K

-921.00%

Name

Name/Position

Position

Shareholding

Change

Dr. Frank H. Laukien, Ph.D.

Chairman of the Board, President, Chief Executive Officer

40.41M

+31932.00%

Dr. Mark Robert Munch, Ph.D.

Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division

95.36K

--

Mr. Richard A. Packer

Independent Director

85.88K

+4972.00%

Mr. Gerald N. Herman

Chief Financial Officer, Executive Vice President

70.13K

+20621.00%

Dr. Falko Busse, Ph.D.

President - Bruker BioSpin Group

35.59K

+9282.00%

Mr. John A. Ornell, CPA

Independent Director

31.91K

+3767.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Product

691.10M

80.31%

Product And Service Other

169.40M

19.69%

Service and other revenue

169.40M

19.69%

By RegionUSD

Name

Revenue

Proportion

Rest of Europe

241.20M

28.03%

United States

226.00M

26.26%

Rest of Asia Pacific

130.70M

15.19%

China

121.80M

14.15%

Germany

71.30M

8.29%

Other

69.50M

8.08%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Product

691.10M

80.31%

Product And Service Other

169.40M

19.69%

Service and other revenue

169.40M

19.69%

Shareholding Stats

Updated: Sun, Feb 1

Shareholders

Shareholder Types

Shareholders

Proportion

Laukien (Frank H)

26.60%

Orbis Investment Management Ltd.

9.31%

Fidelity Management & Research Company LLC

7.52%

The Vanguard Group, Inc.

6.74%

Pallas Capital Advisors LLC

6.24%

Other

43.60%

Shareholders

Proportion

Laukien (Frank H)

26.60%

Orbis Investment Management Ltd.

9.31%

Fidelity Management & Research Company LLC

7.52%

The Vanguard Group, Inc.

6.74%

Pallas Capital Advisors LLC

6.24%

Other

43.60%

Shareholder Types

Shareholders

Proportion

Investment Advisor

51.09%

Individual Investor

31.97%

Investment Advisor/Hedge Fund

25.89%

Hedge Fund

8.24%

Research Firm

2.61%

Pension Fund

1.15%

Sovereign Wealth Fund

0.76%

Bank and Trust

0.34%

Insurance Company

0.21%

Institutional Shareholding



Updated: Mon, Dec 8

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

887

137.27M

94.12%

+111.45K

2025Q3

908

137.16M

94.45%

+8.73M

2025Q2

904

127.18M

89.58%

+1.13M

2025Q1

886

125.13M

85.85%

-5.11M

2024Q4

855

125.47M

82.99%

+4.02M

2024Q3

812

120.93M

80.76%

+2.25M

2024Q2

782

118.65M

76.64%

+5.15M

2024Q1

766

113.09M

82.81%

-916.64K

2023Q4

748

112.27M

83.16%

-472.55K

2023Q3

723

112.40M

83.64%

-8.12M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Laukien (Frank H)

40.41M

26.6%

+31.93K

+0.08%

Aug 15, 2025

Orbis Investment Management Ltd.

14.15M

9.31%

+9.47M

+202.38%

Sep 30, 2025

Fidelity Management & Research Company LLC

11.42M

7.52%

+3.95M

+52.90%

Sep 30, 2025

The Vanguard Group, Inc.

10.38M

6.83%

-23.67K

-0.23%

Sep 30, 2025

Pallas Capital Advisors LLC

9.48M

6.24%

-20.70K

-0.22%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

9.22M

6.07%

-179.94K

-1.91%

Sep 30, 2025

Laukien (Joerg C)

7.52M

4.95%

--

Apr 01, 2025

T. Rowe Price Investment Management, Inc.

6.38M

4.2%

-5.05M

-44.19%

Sep 30, 2025

State Street Investment Management (US)

3.74M

2.46%

-44.57K

-1.18%

Sep 30, 2025

Edmond de Rothschild Asset Management (France) S.A.

3.17M

2.08%

+1.66M

+110.32%

Sep 30, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

First Trust NYSE Arca Biotechnology Index Fund

3.71%

ProShares Nanotechnology ETF

3.34%

State Street SPDR S&P Kensho Future Security ETF

1.27%

Ballast Small/Mid Cap ETF

1.13%

AB Disruptors ETF

0.63%

Invesco NASDAQ Future Gen 200 ETF

0.61%

State Street SPDR S&P Kensho New Econ Comp ETF

0.57%

iShares Health Innovation Active ETF

0.4%

iShares Biotechnology ETF

0.36%

JPMorgan Active Small Cap Value ETF

0.31%

First Trust NYSE Arca Biotechnology Index Fund

Proportion3.71%

ProShares Nanotechnology ETF

Proportion3.34%

State Street SPDR S&P Kensho Future Security ETF

Proportion1.27%

Ballast Small/Mid Cap ETF

Proportion1.13%

AB Disruptors ETF

Proportion0.63%

Invesco NASDAQ Future Gen 200 ETF

Proportion0.61%

State Street SPDR S&P Kensho New Econ Comp ETF

Proportion0.57%

iShares Health Innovation Active ETF

Proportion0.4%

iShares Biotechnology ETF

Proportion0.36%

JPMorgan Active Small Cap Value ETF

Proportion0.31%

Dividend



A total of 113.60M USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Nov 04, 2025

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Jan 02, 2026 going ex on Dec 08, 2025

Dec 08, 2025

Jan 02, 2026

Dec 08, 2025

Aug 12, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Oct 03, 2025 going ex on Sep 23, 2025

Sep 23, 2025

Oct 03, 2025

Sep 23, 2025

May 15, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 27, 2025 going ex on Jun 16, 2025

Jun 16, 2025

Jun 27, 2025

Jun 16, 2025

Feb 21, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025

Mar 17, 2025

Mar 28, 2025

Mar 17, 2025

Nov 18, 2024

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024

Dec 02, 2024

Dec 16, 2024

Dec 02, 2024

Aug 14, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024

Sep 02, 2024

Sep 16, 2024

Aug 30, 2024

May 15, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024

Jun 03, 2024

Jun 17, 2024

Jun 03, 2024

Feb 16, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024

Mar 01, 2024

Mar 15, 2024

Feb 29, 2024

Nov 20, 2023

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023

Dec 01, 2023

Dec 15, 2023

Nov 30, 2023

Aug 14, 2023

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 15, 2023 going ex on Aug 31, 2023

Sep 01, 2023

Sep 15, 2023

Aug 31, 2023

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data